UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Colorectal cancer

The Lancet (British edition), 2010-03, Vol.375 (9719), p.1030-1047

2010

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma

Journal of surgical oncology, 2020-06, Vol.121 (8), p.1320-1328

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years

European journal of cancer (1990), 2022-03, Vol.163, p.1-15

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients

NPJ precision oncology, 2021-10, Vol.5 (1), p.95-95, Article 95

2021

Link zum Volltext

Verfügbarkeit prüfen

Predictive and prognostic markers in the treatment of metastatic colorectal cancer (mCRC): personalized medicine at work

Hematology/oncology clinics of North America, 2015-02, Vol.29 (1), p.43

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer

Cancer chemotherapy and pharmacology, 2017-12, Vol.80 (6), p.1161-1169

2017

Link zum Volltext

Verfügbarkeit prüfen

Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis

BMC cancer, 2020-11, Vol.20 (1), p.1149-1149, Article 1149

2020

Link zum Volltext

Verfügbarkeit prüfen

Ganoderma Lucidum induces oxidative DNA damage and enhances the effect of 5-Fluorouracil in colorectal cancer in vitro and in vivo

Mutation research, 2019-09, Vol.845, p.403065, Article 403065

2019

Link zum Volltext

Verfügbarkeit prüfen

Protein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together

Expert opinion on pharmacotherapy, 2013-11, Vol.14 (16), p.2203-2220

2013

Link zum Volltext

Verfügbarkeit prüfen

A randomized, phase II study of the anti‐insulin‐like growth factor receptor type 1 (IGF‐1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer

Cancer medicine (Malden, MA), 2014-08, Vol.3 (4), p.988-997

2014

Link zum Volltext

Verfügbarkeit prüfen

Comparative Effectiveness of Neoadjuvant Chemoradiation Versus Upfront Surgery in the Management of Recto-Sigmoid Junction Cancer

Clinical colorectal cancer, 2018-09, Vol.17 (3), p.e557-e568

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical activity of patupilone in patients with pretreated advanced/ metastatic colon cancer: results of a phase I dose escalation trial

British journal of cancer, 2011-11, Vol.105 (11), p.1646-1653

2011

Link zum Volltext

Verfügbarkeit prüfen

Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy

Cancer letters, 1997-09, Vol.118 (1), p.29-35

1997

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetic aspects in treatment of colorectal cancer--an update

Pharmacogenomics, 2003-11, Vol.4 (6), p.767

2003

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study

Investigational new drugs, 2004-08, Vol.22 (3), p.335-341

2004

Link zum Volltext

Verfügbarkeit prüfen

Screening & staging of colorectal cancer

Cancer imaging, 2014-10, Vol.14 (9022), p.O8-O8, Article O8

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of supervised aerobic exercise on cardiorespiratory fitness and patient-reported health outcomes in colorectal cancer patients undergoing adjuvant chemotherapy—a pilot study

Supportive care in cancer, 2022-03, Vol.30 (3), p.1945-1955

2022

Link zum Volltext

Verfügbarkeit prüfen

Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades

BMC cancer, 2014-11, Vol.14 (1), p.816-816, Article 816

2014

Link zum Volltext

Verfügbarkeit prüfen

Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer

The New England journal of medicine, 2004-10, Vol.351 (17), p.1731-1740

2004

Link zum Volltext

Verfügbarkeit prüfen

Multicenter phase III randomized trial comparing laparoscopy and laparotomy for colon cancer surgery in patients older than 75 years: the CELL study, a Fédération de Recherche en Chirurgie (FRENCH) trial

BMC cancer, 2019-12, Vol.19 (1), p.1185-1185, Article 1185

2019

Link zum Volltext

Verfügbarkeit prüfen

The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives

Critical reviews in oncology/hematology, 2023-06, Vol.186, p.103990-103990, Article 103990

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer

World journal of gastroenterology : WJG, 2016-06, Vol.22 (23), p.5332-5341

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaColorectal Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(32)
Newsletter-Artikel
(2)

Sprache

Englisch
(34)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(26)
Oncology
(22)
Chemotherapy
(19)
Aged
(16)
Female
(16)
Male
(15)
Colorectal Neoplasms - Pathology
(14)
Middle Aged
(14)
Tumors
(14)
Colorectal Neoplasms - Drug Therapy
(13)
Metastasis
(12)
Antineoplastic Agents - Therapeutic Use
(11)
Cancer
(11)
Patients
(11)
Clinical Trials
(10)
Adult
(9)
Cancer Therapies
(9)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Colorectal cancer

Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years

Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients

Predictive and prognostic markers in the treatment of metastatic colorectal cancer (mCRC): personalized medicine at work

Randomized study of etirinotecan pegol versus irinotecan as second-line treatment for metastatic colorectal cancer

Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis

Ganoderma Lucidum induces oxidative DNA damage and enhances the effect of 5-Fluorouracil in colorectal cancer in vitro and in vivo

Protein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together

A randomized, phase II study of the anti‐insulin‐like growth factor receptor type 1 (IGF‐1R) monoclonal antibody robatumumab (SCH 717454) in patients with advanced colorectal cancer

Comparative Effectiveness of Neoadjuvant Chemoradiation Versus Upfront Surgery in the Management of Recto-Sigmoid Junction Cancer

Clinical activity of patupilone in patients with pretreated advanced/ metastatic colon cancer: results of a phase I dose escalation trial

Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy

Pharmacogenetic aspects in treatment of colorectal cancer--an update

A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study

A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial

Screening & staging of colorectal cancer

Effects of supervised aerobic exercise on cardiorespiratory fitness and patient-reported health outcomes in colorectal cancer patients undergoing adjuvant chemotherapy—a pilot study

Multimodal therapy in treatment of rectal cancer is associated with improved survival and reduced local recurrence - a retrospective analysis over two decades

Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer

Multicenter phase III randomized trial comparing laparoscopy and laparotomy for colon cancer surgery in patients older than 75 years: the CELL study, a Fédération de Recherche en Chirurgie (FRENCH) trial

The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives

Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer

Aktive Filter

Suchergebnisse filtern